Posted by Michael Wonder on 06 May 2021
CMS increases Medicare payment for COVID-19 monoclonal antibody infusions
6 May 2021 - New payment policy for at-home administration.
As part of the on-going response to address the COVID-19 pandemic, CMS has increased the Medicare payment rate for administering monoclonal antibodies to treat beneficiaries with COVID-19, continuing coverage under the Medicare Part B COVID-19 vaccine benefit.
Beneficiaries pay nothing out of pocket, regardless of where the service is furnished – including in a physician’s office, healthcare facility or at home.
